D3 BIO
Live / Registered — Registered (as of 25 Nov 2025)
What this means for you
Registered since 25 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90662890
- Registration number
- 8036017
- Mark type
- Design + words
- Filed
- 22 Apr 2021
- Published for opposition
- 25 Jul 2023
- Registered
- 25 Nov 2025
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 042 — Scientific and technological services: Drug evaluation, namely, pharmaceutical product evaluation; pharmaceutical research; pharmaceutical drug development services; research services in the field of pharmaceutical drugs; scientific research for medical purposes in the field of cancer; biological research; scientific research in the nature of conducting clinical trials for others; medical research; research and development of antibodies; development of pharmaceutical preparations and pharmaceuticals; none of the foregoing in the field of radiation oncology
Owner
- D3 Bio (Wuxi) Co., Ltd., Jiangsu Province, CN
- D3 Bio (Wuxi) Co., Ltd., Jiangsu Province, CN
- D3 Bio (Wuxi) Co., Ltd., Jiangsu Province, CN
Prosecution history
- 25 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 18 Mar 2025 — NOTICE OF ALLOWANCE CANCELLED
- 04 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Mar 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 19 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2024 — SOU EXTENSION 2 GRANTED
- 19 Sept 2024 — SOU EXTENSION 2 FILED
- 19 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2024 — SOU EXTENSION 1 GRANTED
- 07 Mar 2024 — SOU EXTENSION 1 FILED
- 07 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT